Aligos Therapeutics (ALGS)

• Market cap: $37.9M
• 1 day: -5.84%
• 5 days: -16.26%
• 1 month: -10.77%
• 3 months: -24.51%
• 6 months: -35.41%
• Year to date: -32.86%
• 1 year: 14.37%
• 5 years: -99%
• 10 years: -98.35%
• Sector: Healthcare
• Industry: Biotechnology

About: Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.

Employees: 82